Global Effervescent Tablet Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Effervescent Tablet Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Market Overview:

The latest research study on the global Effervescent Tablet market finds that the global Effervescent Tablet market reached a value of USD 5348.01 million in 2022. It’s expected that the market will achieve USD 7244.03 million by 2028, exhibiting a CAGR of 5.19% during the forecast period.

Opportunities

In addition to the vitamin effervescent tablets we see on a daily basis, effervescent tablets are also used in prescription medicines. The range is relatively wide, providing people with a new way of medication. Young people are easy to carry and organize, for effervescence Film, generally accepted.
Effervescent tablets can be dissolved in liquids such as water or juice, which means that their mouthfeel is usually better than regular tablets. Conventional tablets dissolve slowly, which can result in reduced absorption, while effervescent tablets dissolve quickly and completely, which means you can take advantage of these ingredients. Once the regular tablets are ingested, they will gradually dissolve in the stomach. The advantage of effervescent tablets is that they can dissolve completely and uniformly. At the same time, it can also increase water intake and promote body metabolism.

Region Overview:

From 2023-2028, USA is estimated to witness robust growth prospects.

Company Overview:

The top three companies are Bayer, GlaxoSmithKline and Reckitt Benckiser LLC with the revenue market share of 22.65%, 17.28% and 10.41% in 2018.

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Their products and services are designed to benefit people and improve their quality of life. At the same time, they aim to create value through innovation, growth and high earning power.

A science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.

They have 3 global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.
They aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our 3 global businesses, scientific and technical know-how and talented people.

Segmentation Overview:

Among different product types, Daily-used Tablet segment is anticipated to contribute the largest market share in 2028.

Application Overview:

By application, the Individual segment occupied the biggest share from 2018 to 2022.

Key Companies in the global Effervescent Tablet market covered in Chapter 3:

Herbalife Nutrition
GlaxoSmithKline
Reckitt Benckiser LLC
Swisse
Nuun
Yabao Pharmaceutical Group Co., Ltd
Zhejiang CONBA Pharmaceutical Co., Ltd.
Bliss GVS
Sanotact
Bayer
By-health

In Chapter 4 and Chapter 14.2, on the basis of types, the Effervescent Tablet market from 2018 to 2029 is primarily split into:

Prescription-based Tablet
Daily-used Tablet

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Effervescent Tablet market from 2018 to 2029 covers:

Individual
Clinics
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)